Cargando…

Direct testing by VITEK(®) 2: A dependable method to reduce turnaround time in Gram-negative bloodstream infections

CONTEXT: Bloodstream infections pose a major health-care burden worldwide. Routine microbiological methods are time-consuming, thereby delaying appropriate treatment. AIMS: The aim of this study is to evaluate the method of direct testing of identification (ID) and antimicrobial susceptibility testi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barman, Purabi, Chopra, Shimpi, Thukral, Tarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052814/ https://www.ncbi.nlm.nih.gov/pubmed/30078959 http://dx.doi.org/10.4103/JLP.JLP_11_18

Ejemplares similares

Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates
por: Khurana, Surbhi, et al.
Publicado: (2020)

Direct identification and susceptibility testing of Gram-negative bacilli from turbid urine samples using VITEK2
por: Angaali, Neelima, et al.
Publicado: (2018)

An Evaluation of Vitek2™ Direct Susceptibility Testing (DST) of  Gram-Negative Bacteria (GNB) from Positive Blood Cultures (+BC).
por: Gregson, Daniel, et al.
Publicado: (2017)

Evaluation of the Performance of Direct Susceptibility Test by VITEK-2 from Positively Flagged Blood Culture Broth for Gram-Negative Bacilli
por: Kavipriya, D, et al.
Publicado: (2021)

2067. Novel Methodology for Same-Day Antimicrobial Susceptibility Testing on VITEK(®)2 for Gram-Negative Rod Bacteremia
por: Hogan, Catherine, et al.
Publicado: (2018)

Electronic nose versus VITEK 2 system for the rapid diagnosis of bloodstream infections
por: Mohamed, Ehab I., et al.
Publicado: (2023)

649. Clinical Implementation of a Rapid Susceptibility Testing Procedure, Directly From a Positive Blood Culture Using the Vitek®2 System on Gram Negative Rods
por: Henry, Charma, et al.
Publicado: (2020)

568. Evaluation of the VITEK 2 XL Antimicrobial Susceptibility Testing for Non-fermenter Gram-Negative Bacilli: The Importance of Continuing to Monitor AST Systems
por: Carvalhaes, Cecilia G, et al.
Publicado: (2023)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

Fastidious Gram-Negatives: Identification by the Vitek 2 Neisseria-Haemophilus Card and by Partial 16S rRNA Gene Sequencing Analysis
por: Sönksen, Ute Wolff, et al.
Publicado: (2010)

Direct Urine Resistance Detection Using VITEK 2
por: Torres-Sangiao, Eva, et al.
Publicado: (2022)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections
por: Shulder, Stephanie, et al.
Publicado: (2019)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
por: Waters, Jessica, et al.
Publicado: (2023)

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
por: Claeys, Kimberly, et al.
Publicado: (2017)

141. Use of Rapid Diagnostic Testing in Gram-negative Bloodstream Infections with and without Antimicrobial Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2019)

Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system
por: Lupetti, A., et al.
Publicado: (2009)

Subspecialized radiological reporting reduces radiology report turnaround time
por: Zabel, Andreas Otto Josef, et al.
Publicado: (2020)

Improving theatre turnaround time
por: Fletcher, Daniel, et al.
Publicado: (2017)

Turnaround - analysis
por: Venturini Delsolaro, W
Publicado: (2012)

An Important and Often Ignored Turnaround Time in Radiology – Clinician Turnaround Time: Implications for Musculoskeletal Radiology
por: Mayer, Michael, et al.
Publicado: (2019)

Performance of TDR-300B and VITEK®2 for the identification of Pseudomonas aeruginosa in comparison with VITEK®-MS
por: Moehario, Lucky Hartati, et al.
Publicado: (2021)

59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections
por: Bock, Andrew J, et al.
Publicado: (2021)

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients
por: Laporte-Amargos, Julia, et al.
Publicado: (2023)

Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2020)

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections
por: Dambroso-Altafini, Daniela, et al.
Publicado: (2022)

Infective Endocarditis: Identification of Catalase-Negative, Gram-Positive Cocci from Blood Cultures by Partial 16S rRNA Gene Analysis and by Vitek 2 Examination
por: Abdul-Redha, Rawaa Jalil, et al.
Publicado: (2010)

Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
por: Larremore, Daniel B., et al.
Publicado: (2020)

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
por: Larremore, Daniel B., et al.
Publicado: (2021)

570. Impact of a Blood Culture Direct Identification Procedure on Time to Identification for Gram-Negative Organisms and Antimicrobial Management in Bloodstream Infections
por: Coppinger, Corwin, et al.
Publicado: (2023)

Combined procalcitonin and hemogram parameters contribute to early differential diagnosis of Gram‐negative/Gram‐positive bloodstream infections
por: Gao, Qiqing, et al.
Publicado: (2021)

Cefepime-Zidebactam (WCK 5222) Activity Tested against Gram-negative Organisms Causing Bloodstream Infections Worldwide
por: Sader, Helio S, et al.
Publicado: (2017)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
por: Al-Hasan, Majdi N.
Publicado: (2020)

Replication Dynamics for Six Gram-Negative Bacterial Species during Bloodstream Infection
por: Anderson, Mark T., et al.
Publicado: (2021)

224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
por: Parsons, Joshua B, et al.
Publicado: (2023)

Project and program turnaround
por: Pavelko, Thomas
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_squ5k2ic6u1q86m6a9trpqfpu1